Plain-English translation of NCT07201194 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether acupuncture and acupressure, when used together with standard anti-nausea medication, can reduce chemotherapy-induced nausea more effectively than anti-nausea medication alone. About 90 patients who are experiencing nausea during cancer treatment will participate. Half will receive acupuncture and acupressure in addition to their regular anti-nausea medicines, while the other half will receive only the standard anti-nausea medicines.
Chemotherapy-induced nausea is a common and distressing side effect that affects many cancer patients, even when they take anti-nausea medications. Researchers want to see if adding acupuncture to standard treatment might provide better relief and improve quality of life during cancer care.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly assigned to one of two groups. One group will receive acupuncture and acupressure sessions along with their regular anti-nausea medicine, while the other group will continue with anti-nausea medicine alone. You'll have your nausea levels and other cancer-related symptoms checked at the start, then again at 8 days and 22 days after you enroll. The trial is designed to fit with your regular chemotherapy schedule.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Denmark